Steven S. Brooks, MD MBA FACC is a multi-faceted health care consultant, publisher, cardiologist and clinical trialist.

Currently, Dr. Brooks is a principal in Brooks Medtech, LLC, a Senior Analyst with Popper and Company, and an Expert Consultant with NDA Partners.  In these consulting roles, he is active in developing thought leadership, content and consultation on multiple interconnected strategic areas.

Dr. Brooks is a Product Development Contributor to StepWise Medical, a medical device accelerator formed as a collaboration of medical device experts, engineers and commercialization partners.

In addition, he serves as Chief Medical Officer of Global Interconnect, a US-Asia design, engineering, and manufacturing firm with a primary focus in electrosurgical devices.

Previously, he served from 2015 to 2016 as the Vice President of Regulatory Affairs and Health Economics for Ablative Solutions, Inc., a medical device manufacture with a catheter based product which performs renal denervation for the treatment of hypertension.

Prior to joining Ablative Solutions, Dr. Brooks was the Chief Innovation Officer at Sage Growth Partners (SGP), a healthcare consulting firm with expertise in healthcare.  At Sage, he developed the Medtech Practice and managed the Canton Health Ventures incubator, managing incubator tenants, as well as launching ISOSight Medical, Inc, a line-of-sight ultrasound device company which is based off of intellectual property licensed from the University of Pittsburgh.

Previously, Dr. Brooks served as a medical officer for the Food and Drug Administration in the Peripheral Interventional Devices Branch and Interventional Cardiology Devices Branches. In this role he performed medical device review of cardiac and vascular-related products throughout the full product lifecycle.  

Prior to joining the FDA in 2007, he was an Interventional Cardiologist, triple boarded in Internal Medicine, General Cardiology and Interventional Cardiology.  He completed an MBA at the Johns Hopkins Carey School of Business in the Business of Medicine Program, and has continued to interact with the program as an adjunct faculty member lecturing on drug and device regulation and business strategy and consulting with students on their projects in the “Discovery to Market” course and the graduate and undergraduate programs as an advisor to the Johns Hopkins Centre for Bioengineering Innovation & Design (CBID). He is also a grant reviewer for the Maryland State TEDCO program for multiple funds and a medical executive in the mdPACE commercialization program.